Skip to main content
. 2014 Mar 22;14:50. doi: 10.1186/1471-2466-14-50

Table 1.

Characteristics of the sarcoidosis patients

Patient characterizations
 Pulmonary function tests
Patient HLA DRB1 type CD4/CD8 ratio Lymphocytes in BAL (%) Chest X-ray stage* VC (%) FEV 1 (%) DL co (%)
1
 4, 15
 17
 49
 I
 93
 100
 84
2
 3
 11.1
 25
 I
 76
 82
  
3
 1, 3
 1.8
 6.6
 II
 82
 81
 87
4
 NA
 10.3
 64
 I
 69
 63
 58
5
 13, 14
 11.8
 34
 II
 108
 103
 90
6
 4, 8
 8.9
 32
 I
 90
 76
 73
7
 4, 15
 7.3
 16.8
 II
  
 68
  
8
 1, 13
 14.4
 14.2
 I
 80
 79
  
9
 3, 16
 11.3
 25.6
 I
 84
 89
  
10
 3, 15
 2.2
 7
 I
 96
 107
 111
11
 13, 15
 3.6
 12.4
 III
 73
 60
 93
12
 4, 15
 7.2
 25.6
 I
 119
 124
 111
13
 15
 3
 50
 II
 85
 80
  
14
 4, 7
 2.4
 7.6
 IV
 65
 62
 55
15 4, 8 6 19 III 99 86 78

NA = not analysed, VC = vital capacity (% of reference value), FEV1 = forced expiratory volume in one second, DLco = diffusing capacity of the lung for carbon monoxide. *Chest X-ray stages: I) Bilateral hilar lymphadenopathy (BHL) without pulmonary infiltrates, II) BHL with pulmonary infiltrates, III) pulmonary infiltrates without BHL, IV) fibrosis with distortions.